Roger Mills

Filings by Roger Mills span 2 companies, the busiest being Acadia Pharmaceuticals Inc and Addex Therapeutics Ltd. Over a trading history stretching from 1 April 2013 to 2 September 2026, the count stands at 7 filings.

The open-market record consists of 3 sales worth €1.6M, with no purchase. Besides market trades, the filings include 1 share grant and 2 option exercises.

On 4 September 2026 came the latest disclosure, a share grant in Addex Therapeutics Ltd. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.